Skip to main content

Sallie R. Permar

NIH Rank #706
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8860486Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pediatrics
  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$6.6M
Full award amounts, FY2024
Award Records
10
Records listing this PI
Award-Linked Rank
#706
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Sallie R. Permar. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Sallie R. Permar as a PI. Multi-PI records show the full award amount for context.

  • 5K12HD000850-40K12
    Pediatric Scientist Development Program
    $1.5M
    award amount
  • 5R01AI161008-04R01
    Early life B cell responses and inflammation following SARS-CoV-2 infection
    $852.9K
    award amount
  • 5R01AI162245-04R01
    Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission
    $828.2K
    award amount
  • 5R01AI173333-02R01
    Identifying and modeling immune correlates of protection against congenital CMV transmission after primary maternal infection
    $822.3K
    award amount
  • 5R01HD103721-03R01
    Role of maternal-fetal interface NK cells in pregnancy maintenance and congenital CMV transmission
    $699.1K
    award amount
  • 5P01AI117915-10P01
    Early Life Vaccination to Prevent HIV acquisition during Adolescence
    $668.2K
    award amount
  • 5R38AI174255-02R38
    Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)
    $448.9K
    award amount
  • 2P01AI129859-07P01
    Immunologic strategies to prevent congenital cytomegalovirus transmission and disease in rhesus monkeys
    $307.4K
    award amount
  • 1R21AI176451-01A1R21
    Improving HCMV vaccine-elicited immunity by targeting viral Fc receptors
    $247K
    award amount
  • 5P01AI178377-02P01
    Determinants of HIV broadly-neutralizing antibody precursor induction in infants
    $242.5K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Sallie R. Permar as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Weill Cornell Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #706
  7. 2024
    Entered Top 25% Nationally
    Ranked #706
  8. 2024
    Entered Top 10% Nationally
    Ranked #706
  9. 2024
    Entered Top 5% Nationally
    Ranked #706
  10. 2025
    $10M Cumulative Funding
  11. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  12. 2025
    R01 Grant Holder
  13. 2025
    Program/Center Grant Leader